PAPER Rosen RF, Fritz JJ, Dooyema J, Cintron AF, Hamaguchi T, Lah JJ, LeVine H 3rd, Jucker M, Walker LC
SEARCH RESULTS
331209 RESULTS
PAPER Di Domenico F, Coccia R, Butterfield DA, Perluigi M
Circulating biomarkers of protein oxidation for Alzheimer disease: Expectations within limits.
Biochim Biophys Acta. 2011 Dec;1814(12):1785-95. PubMed: 22019699PAPER Graham RK, Ehrnhoefer DE, Hayden MR
Caspase-6 and neurodegeneration.
Trends Neurosci. 2011 Dec;34(12):646-56. PubMed: 22018804PAPER Hybertson BM, Gao B, Bose SK, McCord JM
Oxidative stress in health and disease: the therapeutic potential of Nrf2 activation.
Mol Aspects Med. 2011 Aug;32(4-6):234-46. PubMed: 22020111PAPER Vidoni ED, Billinger SA, Lee C, Hamilton J, Burns JM
The Physical Performance Test Predicts Aerobic Capacity Sufficient for Independence in Early-Stage Alzheimer Disease.
J Geriatr Phys Ther. 2011 Oct 20; PubMed: 22020383PAPER Austrom MG, Dickinson SL, Denny SS, Matthews BR, Gao S, Lu Y
Frontotemporal dementia caregivers and researchers: partnering for brain donation.
Am J Alzheimers Dis Other Demen. 2011 Sep;26(6):477-83. PubMed: 22021861PAPER Sherman A, Bowser R, Grasso D, Power B, Milligan C, Jaffa M, Cudkowicz M
Proposed BioRepository platform solution for the ALS research community.
Amyotroph Lateral Scler. 2011 Jan;12(1):11-6. PubMed: 21128868PAPER Qureshi M, Shui A, Dibernardo AB, Brown RH, Schoenfeld DA, Cudkowicz ME
Medications and laboratory parameters as prognostic factors in amyotrophic lateral sclerosis.
Amyotroph Lateral Scler. 2008 Dec;9(6):369-74. PubMed: 18608098PAPER Mendonça DM, Martins SC, Higashi R, Muscara MN, Neto VM, Chimelli L, Martinez AM
Neurofilament heavy subunit in cerebrospinal fluid: a biomarker of amyotrophic lateral sclerosis?
Amyotroph Lateral Scler. 2011 Mar;12(2):144-7. PubMed: 21198418PAPER Shefner JM, Watson ML, Simionescu L, Caress JB, Burns TM, Maragakis NJ, Benatar M, David WS, Sharma KR, Rutkove SB
Multipoint incremental motor unit number estimation as an outcome measure in ALS.
Neurology. 2011 Jul 19;77(3):235-41. PubMed: 21676915PAPER Shefner JM
Statistical motor unit number estimation and ALS trials: the effect of motor unit instability.
Suppl Clin Neurophysiol. 2009;60:135-41. PubMed: 20715375PAPER Shefner JM, Cudkowicz ME, Zhang H, Schoenfeld D, Jillapalli D,
Revised statistical motor unit number estimation in the Celecoxib/ALS trial.
Muscle Nerve. 2007 Feb;35(2):228-34. PubMed: 17058270PAPER Qureshi M, Schoenfeld DA, Paliwal Y, Shui A, Cudkowicz ME
The natural history of ALS is changing: improved survival.
Amyotroph Lateral Scler. 2009 Oct-Dec;10(5-6):324-31. PubMed: 19922119PAPER Miller RG, Moore DH, Forshew DA, Katz JS, Barohn RJ, Valan M, Bromberg MB, Goslin KL, Graves MC, McCluskey LF, McVey AL, Mozaffar T, Florence JM, Pestronk A, Ross M, Simpson EP, Appel SH,
Phase II screening trial of lithium carbonate in amyotrophic lateral sclerosis: examining a more efficient trial design.
Neurology. 2011 Sep 6;77(10):973-9. PubMed: 21813790PAPER Chiò A, Canosa A, Gallo S, Cammarosano S, Moglia C, Fuda G, Calvo A, Mora G,
ALS clinical trials: do enrolled patients accurately represent the ALS population?
Neurology. 2011 Oct 11;77(15):1432-7. PubMed: 21956723Current Filters
No filters selected